Abbott India jumped 5.01% to Rs 17,000 after standalone net profit surged 54.2% to Rs 180.35 crore on 6.5% jump in net sales to Rs 1,064.27 crore in Q1 June 2020 over Q1 June 2019.
Standalone profit before tax (PBT) soared 29.7% to Rs 242.50 crore in Q1 June 2020 as against Rs 186.95 crore in Q1 June 2019. Current tax expense for the quarter dropped 10.2% to Rs 63.60 crore as against Rs 70.80 crore in Q1 June 2019. The Q1 result was declared after trading hours on Friday, 7 August 2020.
The extended lockdown on account of COVID-19 pandemic has led to a slowdown of demand in some therapeutic areas and resulted in lower sales. Abbott India continues to ensure uninterrupted supply of products to meet the needs of
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app